Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Buck

Showing results (241-250 of 400) with videos related to

Pageof 40
Sort By:
Oncotarget|July 1, 2014
Week one FLT-PET response predicts complete remission to R-CHOP and survival in DLBCLKen Herrmann, Andreas K Buck, Tibor Schuster, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 27, 2019
Imaging Inflammation in Atherosclerosis with CXCR4-Directed <sup>68</sup>Ga-Pentixafor PET/CT: Correlation with <sup>18</sup>F-FDG PET/CTMalte Kircher, Johannes Tran-Gia, Luisa Kemmer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 3, 2021
Novel CYP11B-ligand [<sup>123/131</sup>I]IMAZA as promising theranostic tool for adrenocortical tumors: comprehensive preclinical characterization and first clinical experienceBritta Heinze, Andreas Schirbel, Lukas Nannen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 5, 2023
Molecular imaging of arterial fibroblast activation protein: association with calcified plaque burden and cardiovascular risk factorsAleksander Kosmala, Sebastian E Serfling, Kerstin Michalski, et al.
Clinical Nuclear Medicine|February 8, 2023
Somatostatin Receptor-Directed PET/CT for Therapeutic Decision-Making and Disease Control in Patients Affected With Small Cell Lung CancerSebastian E Serfling, Philipp E Hartrampf, Yingjun Zhi, et al.
Clinical Nuclear Medicine|May 11, 2023
Impact of CXCR4-Directed PET/CT on Staging and Proposed Oncologic Management in Patients With Digestive System TumorsAlexander Weich, Sebastian E Serfling, Wiebke Schlötelburg, et al.
Nuklearmedizin. Nuclear Medicine|August 17, 2022
Clinical Utility of C-Reactive Protein and White Blood Cell Count for Scheduling an [18F]FDG PET/CT in Patients with Giant Cell ArteritisKonstanze V Guggenberger, Marius L Vogt, Steven P Rowe, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 16, 2004
Clinical relevance of imaging proliferative activity in lung nodulesAndreas K Buck, Martin Hetzel, Holger Schirrmeister, et al.
Cell Chemical Biology|March 29, 2023
Structural basis for antibody-mediated neutralization of lymphocytic choriomeningitis virusAlex Moon-Walker, Zeli Zhang, Dawid S Zyla, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 19, 2011
Predictive value of initial 18F-FLT uptake in patients with aggressive non-Hodgkin lymphoma receiving R-CHOP treatmentKen Herrmann, Andreas K Buck, Tibor Schuster, et al.
Pageof 40

Showing results (241-250 of 400) with videos related to

Sort By:
Pageof 40
Oncotarget|July 1, 2014
Week one FLT-PET response predicts complete remission to R-CHOP and survival in DLBCLKen Herrmann, Andreas K Buck, Tibor Schuster, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 27, 2019
Imaging Inflammation in Atherosclerosis with CXCR4-Directed <sup>68</sup>Ga-Pentixafor PET/CT: Correlation with <sup>18</sup>F-FDG PET/CTMalte Kircher, Johannes Tran-Gia, Luisa Kemmer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 3, 2021
Novel CYP11B-ligand [<sup>123/131</sup>I]IMAZA as promising theranostic tool for adrenocortical tumors: comprehensive preclinical characterization and first clinical experienceBritta Heinze, Andreas Schirbel, Lukas Nannen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 5, 2023
Molecular imaging of arterial fibroblast activation protein: association with calcified plaque burden and cardiovascular risk factorsAleksander Kosmala, Sebastian E Serfling, Kerstin Michalski, et al.
Clinical Nuclear Medicine|February 8, 2023
Somatostatin Receptor-Directed PET/CT for Therapeutic Decision-Making and Disease Control in Patients Affected With Small Cell Lung CancerSebastian E Serfling, Philipp E Hartrampf, Yingjun Zhi, et al.
Clinical Nuclear Medicine|May 11, 2023
Impact of CXCR4-Directed PET/CT on Staging and Proposed Oncologic Management in Patients With Digestive System TumorsAlexander Weich, Sebastian E Serfling, Wiebke Schlötelburg, et al.
Nuklearmedizin. Nuclear Medicine|August 17, 2022
Clinical Utility of C-Reactive Protein and White Blood Cell Count for Scheduling an [18F]FDG PET/CT in Patients with Giant Cell ArteritisKonstanze V Guggenberger, Marius L Vogt, Steven P Rowe, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 16, 2004
Clinical relevance of imaging proliferative activity in lung nodulesAndreas K Buck, Martin Hetzel, Holger Schirrmeister, et al.
Cell Chemical Biology|March 29, 2023
Structural basis for antibody-mediated neutralization of lymphocytic choriomeningitis virusAlex Moon-Walker, Zeli Zhang, Dawid S Zyla, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 19, 2011
Predictive value of initial 18F-FLT uptake in patients with aggressive non-Hodgkin lymphoma receiving R-CHOP treatmentKen Herrmann, Andreas K Buck, Tibor Schuster, et al.
Pageof 40